Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Conferences
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
naturereprints
About this site
For librarians
 
NPG Resources
Bioentrepreneur
Nature Reviews Drug Discovery
Nature
Nature Medicine
Nature Genetics
Nature Reviews Genetics
Nature Methods
Nature Chemical Biology
news@nature.com
Clinical Pharmacology & Therapeutics
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Letters
Nature Biotechnology 24, 856 - 863 (2006)
Published online: 2 July 2006; | doi:10.1038/nbt1225

Suppression of vascular permeability and inflammation by targeting of the transcription factor c-Jun

Roger G Fahmy1, Alla Waldman1, Guishui Zhang1, Ainslie Mitchell1, Nicodemus Tedla2, Hong Cai2, Carolyn R Geczy2, Colin N Chesterman1, Michael Perry3 & Levon M Khachigian1

1  Centre for Vascular Research, University of New South Wales, and Department of Haematology, The Prince of Wales Hospital, Sydney NSW 2031, Australia.

2  Cytokine Research Unit, Department of Pathology, University of New South Wales, Sydney NSW 2052, Australia.

3  Department of Physiology and Pharmacology, University of New South Wales, Sydney NSW 2052, Australia.

Correspondence should be addressed to Levon M Khachigian l.khachigian@unsw.edu.au

c-JunVEGFc-JunE-selectinICAM-1VCAM-1VE-cadherinJAM-1PECAM-1p-JNK-1c-FosConventional anti-inflammatory strategies induce multiple side effects, highlighting the need for novel targeted therapies. Here we show that knockdown of the basic-region leucine zipper protein, c-Jun, by a catalytic DNA molecule, Dz13, suppresses vascular permeability and transendothelial emigration of leukocytes in murine models of vascular permeability, inflammation, acute inflammation and rheumatoid arthritis. Treatment with Dz13 reduced vascular permeability due to cutaneous anaphylactic challenge or VEGF administration in mice. Dz13 also abrogated monocyte-endothelial cell adhesion in vitro and abolished leukocyte rolling, adhesion and extravasation in a rat model of inflammation. Dz13 suppressed neutrophil infiltration in the lungs of mice challenged with endotoxin, a model of acute inflammation. Finally, Dz13 reduced joint swelling, inflammatory cell infiltration and bone erosion in a mouse model of rheumatoid arthritis. Mechanistic studies showed that Dz13 blocks cytokine-inducible endothelial c-Jun, E-selectin, ICAM-1, VCAM-1 and VE-cadherin expression but has no effect on JAM-1, PECAM-1, p-JNK-1 or c-Fos. These findings implicate c-Jun as a useful target for anti-inflammatory therapies.


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

 Top
natureproducts

Natureproducts is an online service detailing information about specific products used in this article, you can view the product descriptions, request information and compare with other similar products. The products used are listed in alphabetical order.

A-Z product listingbiocompare
cocktail of four monoclonal antibodies to type II collagen (Chemicon International)
Evans blue dye (Sigma)
Fast Prep FP120 Bio 101 (Thermo Savant)
FuGENE6 (Roche Diagnostics)
LPS (Difco)
Lysing Matrix D homogenizing tubes (Q-BIOgene)
See more natureproducts
 Top
 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
rights and permissionsRights and permissions
Order commercial reprintsOrder commercial reprints
CrossRef lists 9 articles citing this articleCrossRef lists 9 articles citing this article
Save this linkSave this link
Figures & Tables
Supplementary info
Products
Export citation

Open Innovation Challenges

naturejobs

natureproducts

Search buyers guide:

 
Nature Biotechnology
ISSN: 1087-0156
EISSN: 1546-1696
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | Conferences | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2006 Nature Publishing Group | Privacy policy